Fahd Al-Mulla is a Professor of Molecular Medicine. He heads a Molecular Pathology Unit, which aims at delivering state-of-the-art diagnostic, targeted or tailored therapy and research facilities. Currently, his mandate is to build collaborative partnerships, invest institutional outputs, generate capital and resources, and promote public awareness as regards to the importance of scientific research outputs in resolving society’s problems and in expediting the development process. His research activities currently focus on identifying metastasis suppressor genes in colorectal cancer. This search led to the identification of two metastasis suppressors, namely Carbony Reductase and Raf Kinase Inhibitory Protein, which he and his team characterized further recently. Fahd Al-Mulla received his Medical Doctorate and Ph.D. from Glasgow University. He is a Fellow of the Royal College of Physicians of Edinburgh. Fahd Al-Mulla has extensive experience in Theranostics, and intellectual property development. He developed two state-of-the-art laboratories with quality assurance and other certifications.